The Peptide Audit
← The Peptide Audit Weekly
Week of October 26, 2026

MOTS-c: peptide of the week

0
Price drops
0
Back in stock
1
New lab results
Mostly animal & lab studies

What is MOTS-c?

MOTS-c is a 16-amino-acid peptide encoded by mitochondrial DNA — one of a small family of “mitochondrial-derived peptides.”

How it works

Research indicates it can move to the cell nucleus under stress and influence genes involved in metabolism, partly through the AMPK energy-sensing pathway.

What researchers are studying

  • ●Exercise capacity and muscle metabolism in mice
  • ●Cellular stress responses
  • ●Age-related metabolic changes

Where the evidence stands: Not approved by the FDA. Human research is at an early stage.

Recent peer-reviewed research

  1. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
    Sports medicine (Auckland, N.Z.) · 2026 Aug · PubMed ↗
  2. Mitochondrial-Derived Peptide MOTS-c Suppresses Ovarian Cancer Progression by Attenuating USP7-Mediated LARS1 Deubiquitination
    Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024 Nov · PubMed ↗
  3. Mitochondria-derived peptide MOTS-c and its role in OSA pathogenesis: a potential therapeutic target?
    Sleep and biological rhythms · 2025 Jul · PubMed ↗
Read the full MOTS-c guide →

New lab results that week

Free weekly email
Get The Peptide Audit Weekly

Every Monday: the week's price drops and restocks, new third-party lab results, and a plain-English research guide with the latest studies. No spam — unsubscribe anytime.

Educational content only — not medical advice. Prices reflect the week of publication; see the Price Index for current prices. Compounds referenced are sold by third parties for laboratory research use only. The Peptide Audit.